Clearmind Medicine Inc. Company Profile
NASDAQ: CMNDHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Clearmind Medicine at a glance
Clearmind Medicine Inc. (NASDAQ: CMND) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector headquartered in Vancouver, BC, Canada. Clearmind Medicine is led by Dr. Adi Zuloff-Shani Ph.D.. At a market capitalization of $1.3 million, it is considered a small-cap company.
Its SEC Central Index Key (CIK) is 0001892500, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does Clearmind Medicine do?
Clearmind Medicine Inc., a clinical stage pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems. The company develops treatments for alcohol use disorders, binge drinking, and eating disorders, as well as weight loss, obesity, and metabolic syndrome, anxiety disorders, post-traumatic stress disorder, depression, and treatment resistant depression. It develops MEAI compound for the treatment of alcohol use disorder, obesity, and metabolic disorders, as well as an alcohol substitute consumer product; and CM-CMND-001 which is in Phase I/IIa clinical trial for the treatment of alcohol use disorder. In addition, the company has a strategic collaboration with SciSparc Ltd., Yissum Research Development Company of the Hebrew University of Jerusalem, Polyrizon Ltd., and NeuroThera Labs Inc. The company was formerly known as Cyntar Ventures Inc. and changed its name to Clearmind Medicine Inc. in March 2021. The company was incorporated in 2017 and is headquartered in Vancouver, Canada.
Business description based on the company's public filings.
Company information
- Legal name
- Clearmind Medicine Inc.
- Ticker
- NASDAQ: CMND
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- CEO
- Dr. Adi Zuloff-Shani Ph.D.
- Headquarters
- 1220 West 6th Avenue, Vancouver, BC, Canada
- Phone
- 973 536 1016
- Website
- clearmindmedicine.com
- Market cap
- $1.33M
- SEC CIK
- 0001892500
Companies similar to Clearmind Medicine
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| ELABPMGC Holdings Inc. | 1.14 | -10.24% | $1.33M | vs CMND |
| CAPSCapstone Holding Corp. | 1.44 | -9.15% | $1.35M | vs CMND |
| ARTLArtelo Biosciences Inc. | 1.39 | -4.14% | $1.30M | vs CMND |
| APVOAptevo Therapeutics Inc. | 0.4041 | -2.37% | $1.40M | vs CMND |
| JUNSJupiter Neurosciences Inc. | 1.24 | -18.75% | $1.63M | vs CMND |
| PRFXPRF Technologies Ltd. | 0.4758 | -23.68% | $1.66M | vs CMND |
| GOVXGeoVax Labs Inc. | 1.81 | -5.24% | $985.46K | vs CMND |
| BDRXBiodexa Pharmaceuticals plc American Depositary Shs | 1.88 | -3.85% | $982.95K | vs CMND |